Evidence for the loss and recovery of SLAMF9 during human evolution: implications on Dollo's law

Immunogenetics. 2021 Jun;73(3):243-251. doi: 10.1007/s00251-021-01208-7. Epub 2021 Feb 22.

Abstract

Signaling lymphocyte activation molecule family member 9 (SLAMF9) is a cell surface protein of the CD2/SLAM family of leukocyte surface receptors. It is conserved throughout mammals and has roles in the initiation of inflammatory responses and regulation of plasmacytoid dendritic cell function. Through comparison of reference sequences encoding SLAMF9 in human, mouse, and primate sequences, we have determined that the SLAMF9 gene underwent successive mutation events, resulting in the loss of the protein and subsequent recovery of a less stable version. The mutations included a single base pair deletion in the second exon and a change in the splice acceptor site of that same exon. These changes would have had the effect of creating and later repairing a frameshift in the coding sequence. These events took place since the divergence of the human lineage from the chimpanzee-human last common ancestor and represent the first known case of the functional loss and recovery of a gene within the human lineage.

Keywords: Leukocyte; Primate evolution; Receptor structure; SLAMF9.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Base Sequence
  • Biological Evolution*
  • Genetic Predisposition to Disease*
  • Humans
  • Mammals
  • Mutation*
  • Phylogeny
  • Primates
  • Sequence Homology
  • Signaling Lymphocytic Activation Molecule Family / genetics*
  • Signaling Lymphocytic Activation Molecule Family / metabolism*

Substances

  • SLAMF9 protein, human
  • Signaling Lymphocytic Activation Molecule Family